$86.2 Million
Neoleukin Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$110.5 Million
Revance Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$53.6 Million
OptiNose AS
Confidentially Marketed Follow-On Offering
Active Bookrunner
$115.0 Million
Arvinas
Confidentially Marketed Follow-On Offering
Active Bookrunner
$143.8 Million
Ardelyx Inc
Confidentially Marketed Follow-On Offering
Active Bookrunner
$75.2 Million
MeiraGTx Holdings plc
Confidentially Marketed Follow-On Offering
Active Bookrunner
$65.0 Million
Syros Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$31.2 Million
Kiadis Pharma B.V.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$57.9 Million
SeaSpine Holdings Corporation
Confidentially Marketed Follow-On Offering
Active Bookrunner
$143.8 Million
Fate Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.